| Regeneron Pharmaceuticals, Inc. |
Level II |
47 | 171 |
$142,233 |
| Albert Einstein College of Medicine |
Level I |
10 | 10 |
$75,750 |
| Albert Einstein College of Medicine |
Level II |
10 | 10 |
$75,730 |
| Merck Sharp & Dohme LLC |
Level II |
7 | 7 |
$117,000 |
| New York University |
Level I |
7 | 7 |
$66,305 |
| Weill Cornell Medical College |
Level II |
7 | 16 |
$86,137 |
| Weill Cornell Medical College |
Level I |
6 | 15 |
$80,596 |
| Research Foundation for the State University of New York |
Level I |
5 | 5 |
$59,000 |
| Brookhaven National Laboratory |
Level II |
4 | 4 |
$75,678 |
| NYU Grossman School of Medicine |
Level I |
4 | 4 |
$71,263 |
| Regeneron Pharmaceuticals, Inc. |
Level I |
4 | 4 |
$100,193 |
| Regeneron Pharmaceuticals, Inc. |
Level IV |
3 | 3 |
$159,963 |
| Howard Hughes Medical Institute |
Level II |
2 | 2 |
$83,921 |
| The Jackson Laboratory |
Level I |
2 | 2 |
$65,589 |
| Merck Sharp & Dohme LLC |
Level III |
2 | 2 |
$149,200 |
| Research Foundation for the State University of New York |
Level II |
2 | 2 |
$70,149 |
| The Rockefeller University |
Level II |
2 | 2 |
$75,896 |
| WuXi Biologics USA, LLC |
Level II |
2 | 2 |
$113,734 |
| WuXi Biologics USA, LLC |
Level IV |
2 | 2 |
$151,171 |
| Albert Einstein College of Medicine |
Level III |
1 | 1 |
$80,000 |
| Bristol-Myers Squibb Company |
Level II |
1 | 1 |
$98,664 |
| CD Biosciences Inc. |
Level IV |
1 | 1 |
$118,310 |
| Cold Spring Harbor Laboratory |
Level I |
1 | 1 |
$74,300 |
| Columbia University |
Level II |
1 | 1 |
$79,309 |
| Creative Biogene Inc. |
Level IV |
1 | 1 |
$118,310 |
| Croda Inc. |
Level I |
1 | 1 |
$105,000 |
| ELC Beauty LLC |
Level IV |
1 | 1 |
$126,250 |
| GenScript USA Inc. |
Level I |
1 | 1 |
$117,500 |
| Howard Hughes Medical Institute |
Level III |
1 | 1 |
$94,090 |
| Humane Genomics Inc. |
Level IV |
1 | 1 |
$150,000 |
| Ivory Systems, Inc. |
Level I |
1 | 1 |
$87,214 |
| Legend Biotech USA, Inc. |
Level III |
1 | 1 |
$172,000 |
| Memorial Sloan Kettering Cancer Center |
Level II |
1 | 1 |
$230,000 |
| Merck Sharp & Dohme LLC |
Level I |
1 | 1 |
$114,700 |
| Neion Bio Inc. |
Level II |
1 | 1 |
$165,000 |
| New York University |
Level II |
1 | 1 |
$76,055 |
| Nouryon Surface Chemistry LLC |
Level III |
1 | 1 |
$157,000 |
| NOVARTIS PHARMACEUTICALS CORPORATION |
Level II |
1 | 1 |
$89,419 |
| NYU Grossman School of Medicine |
Level II |
1 | 1 |
$85,000 |
| Pacagen, Inc. |
Level IV |
1 | 1 |
$120,000 |
| PFIZER INC. |
Level II |
1 | 1 |
$101,416 |
| PFIZER INC. |
Level IV |
1 | 1 |
$125,504 |
| Regeneron Pharmaceuticals, Inc. |
Level III |
1 | 1 |
$183,257 |
| Research Foundation of CUNY |
Level I |
1 | 1 |
$76,000 |
| Synbio Technologies LLC |
Level I |
1 | 1 |
$80,000 |
| Twist Bioscience Corporation |
Level II |
1 | 1 |
$115,000 |
| XenoBiotic Laboratories, Inc., a div. of WuXi |
Level II |
1 | 1 |
$90,000 |
| Albert Einstein College of Medicine |
Level II |
1 | 1 |
$71,000 |
| The Rockefeller University |
Level I |
1 | 1 |
$74,263 |
| Schrodinger, Inc. |
Level II |
1 | 1 |
$132,600 |
| Merck Sharp & Dohme LLC |
Level I |
2 | 2 |
$80,246 |
| Cold Spring Harbor Laboratory |
Level III |
1 | 1 |
$100,000 |
| Merck Sharp & Dohme LLC |
Level II |
1 | 1 |
$111,400 |
| Albert Einstein College of Medicine |
Level I |
1 | 1 |
$77,000 |
| Albert Einstein College of Medicine |
not stated |
15 | 15 |
$70,000 |
| Rutgers, The State University of New Jersey |
not stated |
4 | 4 |
$82,304 |
| Weill Cornell Medical College |
not stated |
2 | 2 |
$80,313 |
| Columbia University |
not stated |
1 | 1 |
$83,945 |